Based on the advantages of revealing the functional status and molecular expression of
tumor cells, positron emission tomography (PET) imaging has been performed in numerous …

Background: Although many works have supported the utility of PET radiomics, several
authors have raised concerns over the robustness and replicability of the results. This study …

Over the past few years, we have witnessed an exponential increase in the number of
radiomic-related publications. In the PET literature, a PubMed search using a criterion of …

The treatment and management of patients with metastatic melanoma have evolved
considerably in the “era” of personalized medicine. Melanoma was one of the first solid …

Novel therapeutic approaches, consisting of immune check-point inhibitors (ICIs) and
molecularly targeted therapy, have thoroughly changed the clinical management of …

The MM500 study is an initiative to map the protein levels in malignant melanoma tumor
samples, focused on in‐depth histopathology coupled to proteome characterization. The …

Simple Summary In this systematic review, we aim to highlight existing literature devoted to
the study of an association between medical imaging radiomics and cancer biological …

Advanced malignant melanoma represents a public health matter due to its rising incidence
and aggressiveness. Novel therapies such as immunotherapy are showing promising …

The objective of this review was to summarize published radiomics studies dealing with
infradiaphragmatic cancers, blood malignancies, melanoma, and musculoskeletal cancers …

Background/Aim: To evaluate the association between baseline [18F] FDG-PET/CT tumor
burden parameters and disease progression rate after first-line target therapy or …